Community events

24.04.2017 11:00 | Health inequalities in Europe. New insights from comparative studies

Organizer: IUMSP
Venue: Salle Delachaux, Institut universitaire de médecine sociale et préventive, Bâtiment Biopôle 2, Rte de la Corniche 10, niveau 1, 1010 Lausanne
Contact for registration: Mme Catherine Turrian, 021 314 72 72 - catherine.turrian@chuv.ch

Socioeconomic inequalities in mortality are present in all European countries, but their magnitude and development over time is highly variable.

In a series of on-going comparative studies we exploit these variations to identify the macro- and micro-level determinants of these mortality inequalities.

More information

Community events

27.04.2017 11:00 | «Immune Cell-to-Cell communication: Mechanisms of genetic and proteins transfer by exosomes»

Organizer: CIIL
Venue: CLE, Chemin des Boveresses 155, 1066 Epalinges, Room B301

Distinguished Ludwig Lecture series

Prof. Francisco Sanchez Madrid
Universidad Autonoma de Madrid, Spain

Hosts: George Coukos

More information

Community events

27.04.2017 12:15 | «Direct Targeting of KRAS to Treat Cancer»

Organizer: CIIL
Venue: CLE, Chemin des Boveresses 155, 1066 Epalinges, Room B301

Televised to Epalinges B301

The Lola & John Grace Distinguished Lecture in Cancer Research

Dr. Franck McCormick
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA

Host: Douglas Hanahan

More information

Community events

28.04.2017 12:15 | «Is there really a need of a reducing pathway for ER oxidative protein folding: glutathione cytosol to ER trafficking and its regulation by Bip oxidation»

Organizer: CIIL
Venue: CLE, Chemin des Boveresses 155, 1066 Epalinges, Room B301

DB’s Friday seminar

Prof. Michel Toledano
Institute of Biology and Technology Saclay, CEA, Gif-sur-Yvette, France

Host: Nicolas Fasel

More information

Biopôle on the road

04.05.2017 09:00 | Swiss Biotech Day 2017

Organizer: Swiss Biotech
Venue: Congress Center - Basel

Biopôle SA will be present at the next Swiss Biotech Day 2017, on May 4th 2017.

Meet us at our booth # 18

Please contact Mr Olivier Philippe : olivier.philippe at biopole.ch

More information here

Community events

18.05.2017 13:15 | Knowledge translation and self-management in chronic diseases: contexts, tools and practices

Organizer: IUMSP
Venue: IDHEAP, room AULA University of Lausanne - M1 UNIL Mouline
Contact for registration: https://www.unil.ch/stslab & https://www.unil.ch/ip

This interdisciplinary conference aims at crossing concepts and empirical research on the processes through which knowledge translation takes place in the selfmanagement of chronic diseases, with a specific scrutiny of the expected and actual functions of the tools and the context in which translation occurs, on the one hand, and of the difficulties and negotiations that people living with a chronic disease face in gaining autonomy, on the other hand.

More information

Biopôle events

23.05.2017 12:00 | Workshops @Biopôle: Key issues in building a strong patent portfolio in life sciences: A practical approach

Organizer: Biopôle SA & Katzarov
Venue: Biopôle IV. Route de la Corniche 3, Floor -1, Room 1
Contact for registration: info@biopole.ch

Target audience: Companies and research entities active in Life Sciences

During a lunch break time slot Biopôle’s workshops allow their attendees to profit from an expert’s unique experience about a selected subject, and to share experiences and insights in a very convivial hands-on format.

Come and join us on our next workshop and share good food and precious learning:

Key issues in building a strong patent portfolio in life sciences: A practical approach

By Gilles Pfend, partner at KATZAROV

This workshop will provide you with a practical overview of issues that must be considered – and often earlier than might be imagined – by those unfamiliar with the patenting process when setting out to build a strong patent portfolio in life sciences.

Take the opportunity to discuss together with an experienced Patent Attorney the following topics:

-Timing for filing a patent application
-Identifying promising inventions (patentable inventions vs non-patentable inventions)
-Filing one or more (strong) priority application(s)
-International (PCT) patent application filing vs National/Regional filings
-Patent life cycle management (SPC, PTE, specific pharma formulations, etc.)

Tuesday May 23rd 2017
From 12:00 to 14:00
Biopôle IV. Route de la Corniche 3
Floor -1, Room 1
Limited seats – first come first served! For reservations, please contact us at: info@biopole.ch

About the expert:

Gilles Pfend is a partner at KATZAROV, an intellectual property firm specialized in protecting Life Science inventions. He possesses a Ph.D. in Molecular Biology and is a Swiss & European Patent Attorney specialized in pharmaceutical, chemical and biotech inventions.

Since 2001, Gilles counsels local and international Life Sciences clients on strategic issues relating to the development and management of their global patent portfolios.  His practice focuses on preparing and prosecuting patents with a key objective of ensuring that the clients’ business objectives are met.  He also performs patentability analysis, due diligence analyses and renders opinions on freedom-to-operate

LinkedIn Profile: https://www.linkedin.com/in/gilles-pfend-9462403/

 

Biopôle events

13.06.2017 17:30 | From data accumulation to knowledge generation : when bioinformatics becomes the clinician’s companion

Organizer: Next Trends
Venue: Biopôle, Hôtel Aquatis, route de Berne 150, 1010 Lausanne
Contact for registration: https://inartis.wufoo.eu/forms/sedkuxs1dkawiy/

Recent technological advances and high-throughput automated measurements have led to new challenges for biomedical data storage and mining. Computer-based approaches have therefore become essential to help researchers and clinicians extract new insights from these “big”, “small” or “smart» data. How to avoid the garbage-in / garbage-out syndrome? and turn punctual information into contextualised knowledge?

During this upcoming C-Suite, Prof. T. Schwede, Head of the Personalized Health Informatics group at SIB Swiss Institute of Bioinformatics, as well as experts from IBM-Watson and others will explain how bioinformatics are currently revolutionizing the life science and clinical fields, and what are the challenges ahead of this industry, in our ever-connected world.

Program:

17h30-18h00: Welcome and registration

18h00-18h05: Welcome word by Dr med. Thierry Weber, co-organiser

18h05-18h25: Prof Torsten Schwede, Head of the Personalized Health Informatics group, SIB – Swiss Institute of Bioinformatics

18h25-18h45: Dr Costas Bekas, Research Staff Member, IBM Watson

18h45-19h05: Andreas Massoura, Founder and Chief Executive Officer, Saphetor

19h05-19h25: Alan Kalton, Analytics Leader, Ernst & Young Ltd

19h25-20h00: Round table discussion and Q&A

Moderation : Dr med. Thierry Weber, Vivactis

20h00: Networking session & aperitif

Contact for registrationhttps://inartis.wufoo.eu/forms/sedkuxs1dkawiy/

More information: http://www.nextrends.ch/csuite/next-event.html

Biopôle events

15.06.2017 09:00 | SWISSHLG Summer Conference: “Challenges in Financing Life Science Ventures” – Partners or investors, where is the money and what does it come with?

Organizer: Biopôle SA & SwissHLG
Venue: Biopôle/Hotel Aquatis, Lausanne
Contact for registration: https://inartis.wufoo.eu/forms/s8c9p5m0wmv2me/

Swiss HLG Summer Conference
June 15, 2017

Topic: “Challenges in Financing Life Science Ventures” – Partners or Investors, where is the money and what does it come with”?

The 2017 Swiss HLG Summer Conference is organised with Biopole SA in partnership with Inartis, BioAlps and Venturelab, and will be held on the 15th June 2017 at Biopôle, Hotel Aquatis, Lausanne.

The aim of the conference is to establish high-quality networking among the Swiss Romand healthcare companies, including start-ups, medium and large pharma, life science, biotech and other hybrids of healthcare-centric players. There is also the opportunity for selected companies to increase visibility through conducting an elevator pitch of their innovation.

You will hear about success stories (Geneuro, etc.) , panel of experts (from Innovaud, CTI, Inartis etc.), big pharma (Novartis, etc.), VCs (Ysios capital, Omega Funds etc.), rising startups pitches (Amal Therapeutics, Calsiscon, Glycemicon, Inositec, Lunaphore, Versantis, Cellestia Biotech), dilutive/non dilutive funding, business development/networking and much more.

More information about the program: http://www.nextrends.ch/csuite/swiss-hlg.html

Link to the flyer:SwissHLG Summer Conference 2017

Contact for registration: https://inartis.wufoo.eu/forms/s8c9p5m0wmv2me/

 

Biopôle on the road

19.06.2017 09:00 | BIO Convention US – San Diego

Organizer: BIO International Convention 2017
Venue: San Diego

In partnership with the Swiss Biotech Association and BioAlps, Biopôle SA will be present at BIO 2017 in San Diego from June 19-22.

Meet us at our booth #2305 located in the Swiss Biotech Association/BioAlps pavilion !

To schedule a meeting with Biopôle, please contact Mr. Philippe by email: olivier.philippe at biopole.ch

More information here

 

Community events

23.06.2017 11:00 | Risques, preuves et décisions en santé environnementale

Organizer: IUMSP
Venue: Salle Delachaux (étage 01), Institut universitaire de médecine sociale et préventive Bâtiment Biopôle 2, route de la Corniche 10 1010 Lausanne
Contact for registration: Mme Catherine Turrian, 021 314 72 72 - catherine.turrian@chuv.ch

Tous les acteurs ont intérêt à ce que les actions de santé publique soient fondées sur des preuves scientifiques. Mais l’evidence based public health est balbutiante. Pourquoi en est-il ainsi ? Quel est le niveau de preuve requis pour justifier une action ? Ces questions seront discutées avec différents exemples illustrant différents degrés d’incertitude : amiante, phytosanitaires, prion, pollution atmosphérique, changement climatique, nanoparticules.

Plus d’informations

Biopôle events

28.06.2017 09:00 | Healthtech Summit : moving from technologies to solutions

Organizer: TechTour
Venue: Biopôle / Lausanne
Registration deadline: 28.06.2017

For its 8th edition, the Healthtech Summit will return to Lausanne on 26 – 28 June 2017 and will once again focus on showcasing the top 20 medtech and top 20 digital health companies in Europe. The 40 presenting companies, represented by their CEOs and carefully selected by our Selection Committees, will have the opportunity to network with key international investors who can assist them with their global expansion plans. Furthermore, the program will see a balanced and varied succession of corporate presentations, interactive plenary sessions on opportunities related to accelerating investment as well as dedicated networking sessions, Networking Dinner and Lunch. The 2017 edition of the Healthtech Summit will focus on Medtech & Diagnostics and Digital Health.

More information

For any question please contact olivier.philippe at biopole.ch

Biopôle events

10.10.2017 08:00 | The Alpine High-tech Venture Forum (AHVF)

Organizer: TechTour
Venue: Biopôle - Aquatis Hotel & Conference Center
Contact for registration: http://www.e-unlimited.com/register2/0-register.aspx?events_id=1801

The Alpine High-tech Venture Forum (AHVF) will be an unique event for the most innovative entrepreneurs operating in Switzerland and its surrounding regions focused on Life Sciences, Clean Technology and Information Technology to meet and present themselves to active international investors and corporations seeking for  investment and partnerships.

AHVF is hosted by Canton de Vaud  and will be this year at its sixth edition. It plays an important role in the promotion of the dynamic and innovative professional entrepreneurs within the Alpine area. It also promotes the venture capitalists in the Alpine area and the rest of Europe to support their partnerships and investments.

The best high growth companies
Some 40 early-stage companies active in the high technology sectors will be selected to present at the Forum by the Selection Board, who will assess them on the basis of their business potential, technology merit, competitive position, investment interest and  team experience.

More information

For any question please contact olivier.philippe at biopole.ch